BCAS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.42070030687103E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.67749966432041E-10 |
Normal-vs-Stage2 |
1.44920000000326E-06 |
Normal-vs-Stage3 |
2.04309999999319E-05 |
Normal-vs-Stage4 |
3.53019999999038E-06 |
Stage1-vs-Stage2 |
9.883000E-01 |
Stage1-vs-Stage3 |
7.026000E-01 |
Stage1-vs-Stage4 |
5.865400E-01 |
Stage2-vs-Stage3 |
7.680200E-01 |
Stage2-vs-Stage4 |
7.093000E-01 |
Stage3-vs-Stage4 |
4.605800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.25410048801689E-10 |
Normal-vs-AfricanAmerican |
6.11079999934816E-08 |
Normal-vs-Asian |
2.369600E-01 |
Caucasian-vs-AfricanAmerican |
9.771200E-01 |
Caucasian-vs-Asian |
4.944600E-01 |
AfricanAmerican-vs-Asian |
5.365800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.96804811231277E-12 |
Normal-vs-Female |
7.88900000000536E-05 |
Male-vs-Female |
4.243100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.00349999976324E-07 |
Normal-vs-Extreme_Weight |
4.48399983810077E-10 |
Normal-vs-Obese |
1.24110000054856E-08 |
Normal-vs-Extreme_Obese |
1.339660E-03 |
Normal_Weight-vs-Extreme_Weight |
8.895400E-01 |
Normal_Weight-vs-Obese |
9.007800E-01 |
Normal_Weight-vs-Extreme_Obese |
6.773400E-01 |
Extreme_Weight-vs-Obese |
7.630400E-01 |
Extreme_Weight-vs-Extreme_Obese |
5.806800E-01 |
Obese-vs-Extreme_Obese |
7.388200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.368300E-04 |
Normal-vs-Age(41-60Yrs) |
3.53519991058704E-10 |
Normal-vs-Age(61-80Yrs) |
2.02650007885552E-10 |
Normal-vs-Age(81-100Yrs) |
1.68533999999054E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.117600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.750200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.077200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.771200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.413200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.096400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.69828603904898E-12 |
Normal-VS-Type2 PRCC |
7.68649999982607E-07 |
Normal-VS-KIRP CIMP |
4.415600E-04 |
Normal-VS-Unclassified PRCC |
2.05789999485617E-08 |
Type1 PRCC-VS-Type2 PRCC |
1.032820E-01 |
Type1 PRCC-VS-KIRP CIMP |
4.071800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
5.647400E-01 |
Type2 PRCC-VS-KIRP CIMP |
9.490000E-01 |
Type2 PRCC-VS-Unclassified PRCC |
3.930200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
6.077600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.12640002775311E-09 |
Normal-vs-N1 |
2.37929999999942E-05 |
Normal-vs-N2 |
2.336700E-03 |
N0-vs-N1 |
2.324800E-01 |
N0-vs-N2 |
7.564600E-01 |
N1-vs-N2 |
4.035200E-01 |
|
|